Valsartan Dosing for Hypertension
For adults with hypertension, start valsartan at 80-160 mg once daily, with a maximum dose of 320 mg once daily; most patients achieve optimal blood pressure control at 80-160 mg daily. 1
Initial Dosing Strategy
- Start with 80 mg once daily for most patients, or 160 mg once daily if greater blood pressure reduction is needed 1
- The starting dose should be 80 mg in patients who are not volume-depleted, with 160 mg reserved for those requiring more aggressive initial reduction 1
- The antihypertensive effect becomes substantially present within 2 weeks, with maximal reduction generally attained after 4 weeks 1
Dose Titration and Maximum Dosing
- If additional blood pressure lowering is needed beyond the starting dose, increase to a maximum of 320 mg once daily 1
- Valsartan demonstrates dose-dependent efficacy over the range of 80-320 mg daily 1, 2
- However, adding a diuretic provides greater blood pressure reduction than dose increases beyond 80 mg 1
Optimal Dose Range Based on Evidence
- The optimal dose range for essential hypertension is 80-160 mg once daily, balancing efficacy with tolerability 3
- While 160 mg provides sustained AT₁-receptor blockade over 24 hours compared to 80 mg (which shows diminished blockade at 12-24 hours), the incremental blood pressure reduction with doses above 80 mg is relatively small 4, 3
- The 160 mg dose achieves significantly greater AT₁-receptor blockade at 12 and 24 hours compared to 80 mg, though both doses produce similar blockade during the first 6 hours 4
Combination Therapy Considerations
- Valsartan should be combined with a dihydropyridine calcium channel blocker or thiazide diuretic as first-line therapy for most patients with confirmed hypertension (BP ≥140/90 mmHg) 5
- Fixed-dose single-pill combinations are recommended to improve adherence 5
- If blood pressure remains uncontrolled on two-drug combination, escalate to three-drug therapy with a RAS blocker, dihydropyridine calcium channel blocker, and thiazide/thiazide-like diuretic 5
Blood Pressure Targets
- Target treated systolic blood pressure to 120-129 mmHg in most adults to reduce cardiovascular risk 5
- This target should be pursued provided the treatment is well tolerated 5
Common Pitfalls to Avoid
- Do not combine valsartan with an ACE inhibitor, as this increases the risk of hyperkalemia and renal dysfunction 6
- Avoid assuming that higher doses always provide proportionally greater benefit—the dose-response curve flattens above 80 mg for blood pressure reduction 3
- Monitor serum potassium and creatinine within 1-2 weeks after initiating or increasing doses, particularly in patients with baseline renal impairment 6